Breast cancer is biologically heterogeneous, yet conventional clinical decisions rely on static, single-marker proxies (ER, PR, HER2, and Ki-67) that capture only a narrow slice of tumor biology. This mini-review argues that AI-driven multi-omics biomarkers offer a valuable shift toward systems-level, model-derived pro...
D. Stylianakis, R. Sánchez-Bayona, N. Denaro et al.· Frontiers in Pharmacology· 0 citations
The current landscape of mRNA vaccine development for GI malignancies is outlined, with particular attention to delivery strategies and multimodal immunotherapy, with particular attention to delivery strategies and multimodal immunotherapy.
M. Ghidini, Federica Novazzi, N. Denaro et al.· Cells· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.